Page 174 - Remedial Andrology

126. Watts, E.L. Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20
Prospective Studies. Eur Urol, 2018: 585.
https://pubmed.ncbi.nlm.nih.gov/30077399
127. Haider, A. Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy:
Observations from 5-Year Median Followup of 3 Registries. J Urol, 2015: 80.
https://pubmed.ncbi.nlm.nih.gov/24980615
128. Wallis, C.J., et al. Survival and cardiovascular events in men treated with testosterone replacement
therapy: an intention-to-treat observational cohort study. Lancet Diabetes Endocrinol, 2016. 4: 498.
https://pubmed.ncbi.nlm.nih.gov/27165609
129. Gray, H. Recurrence of prostate cancer in patients receiving testosterone supplementation for
hypogonadism. Am J Health-Syst Pharm, 2015: 536.
https://pubmed.ncbi.nlm.nih.gov/25788507
130. Teeling, F., et al. Testosterone Therapy for High-risk Prostate Cancer Survivors: A Systematic Review
and Meta-analysis. Urology, 2019. 126: 16.
https://pubmed.ncbi.nlm.nih.gov/30244116
131. Kardoust Parizi, M., et al. Oncological safety of testosterone replacement therapy in prostate cancer
survivors after definitive local therapy: A systematic literature review and meta-analysis. Urol Oncol,
2019. 37: 637.
https://pubmed.ncbi.nlm.nih.gov/31296421
132. Corona, G., et al. Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of
Observational Studies. J Sex Med, 2018. 15: 1260.
https://pubmed.ncbi.nlm.nih.gov/30145097
133. Malkin, C.J., et al. Low serum testosterone and increased mortality in men with coronary heart
disease. Heart, 2010. 96: 1821.
https://pubmed.ncbi.nlm.nih.gov/20959649
134. Khaw, K.T., et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease,
and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk)
Prospective Population Study. Circulation, 2007. 116: 2694.
https://pubmed.ncbi.nlm.nih.gov/18040028
135. Laughlin, G.A., et al. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab,
2008. 93: 68.
https://pubmed.ncbi.nlm.nih.gov/17911176
136. Shores, M.M., et al. Low serum testosterone and mortality in male veterans. Arch Intern Med, 2006.
166: 1660.
https://pubmed.ncbi.nlm.nih.gov/16908801
137. Vikan, T., et al. Endogenous sex hormones and the prospective association with cardiovascular
disease and mortality in men: the Tromso Study. Eur J Endocrinol, 2009. 161: 435.
https://pubmed.ncbi.nlm.nih.gov/19542243
138. Corona, G., et al. Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic
study. Eur J Endocrinol, 2011. 165: 687.
https://pubmed.ncbi.nlm.nih.gov/21852391
139. Keating, N.L., et al. Diabetes and cardiovascular disease during androgen deprivation therapy for
prostate cancer. J Clin Oncol, 2006. 24: 4448.
https://pubmed.ncbi.nlm.nih.gov/16983113
140. Ohlsson, C., et al. High serum testosterone is associated with reduced risk of cardiovascular events
in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol,
2011. 58: 1674.
https://pubmed.ncbi.nlm.nih.gov/21982312
141. Soisson, V., et al. A J-shaped association between plasma testosterone and risk of ischemic arterial
event in elderly men: the French 3C cohort study. Maturitas, 2013. 75: 282.
https://pubmed.ncbi.nlm.nih.gov/23706278
142. Snyder, P.J., et al. Effects of Testosterone Treatment in Older Men. N Engl J Med, 2016. 374: 611.
https://pubmed.ncbi.nlm.nih.gov/26886521
143. Srinivas-Shankar, U., et al. Effects of testosterone on muscle strength, physical function, body
composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-
blind, placebo-controlled study. J Clin Endocrinol Metab, 2010. 95: 639.
https://pubmed.ncbi.nlm.nih.gov/20061435
144. English, K.M., et al. Low-dose transdermal testosterone therapy improves angina threshold in men
with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation, 2000.
102: 1906.
https://pubmed.ncbi.nlm.nih.gov/11034937

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 173